Experts: Expanding Pfizer vaccine to young kids key to curbing COVID
FacebookTwitterEmail
A sign with the Pfizer logo stands outside the corporate headquarters of Pfizer Canada in Montreal, on Monday, Nov. 9, 2020.Ryan Remiorz / Associated Press
Connecticut health experts welcomed the prediction that the Pfizer-BioNTech COVID-19 vaccine could be cleared as early as September for use in children ages 2 to 11.
Despite the news shared by a Pfizer executive, many pointed out that approval could still be months away.
“We have to understand that the prediction of expanded use by September is just that it is a prediction,” said Dr. Magna Dias, chair of pediatrics Bridgeport Hospital. “We have no information with which to judge whether that would be something we would support or not.”